Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

838
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
838
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

711
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
711
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

742
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
742
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

489
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
489
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

1.2K
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A High-Fidelity and Ancestrally Inclusive Patient-Derived Organoid Platform Resolves Cancer Cell Plasticity in Uterine Carcinosarcoma.

bioRxiv : the preprint server for biology·2026
Same author

Response to progestin-based therapy in endometrial intraepithelial neoplasia: An exploratory biomarker study.

Gynecologic oncology reports·2026
Same author

Stem cell-directed targeted chemotherapy primes drug-resistant metastatic ovarian tumors for elimination by natural killer cells.

Molecular therapy. Oncology·2026
Same author

Comprehensive Molecular Characterization of High-Grade Endometrial Cancer in an Ancestrally Diverse Cohort.

bioRxiv : the preprint server for biology·2026
Same author

A Single-Cell Atlas of Uterine Carcinosarcoma from Diverse Ancestries.

bioRxiv : the preprint server for biology·2026
Same author

Ancestrally Diverse Autologous Patient-Derived Organoid-Immune Cell Coculture Platform for Addressing Immunotherapeutic Outcome Disparities in High-Grade Endometrial Cancer.

Cancer research communications·2026

Related Experiment Video

Updated: Apr 6, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K

Association Between Statin Use and Endometrial Cancer Survival.

Nicole S Nevadunsky1, Anne Van Arsdale, Howard D Strickler

  • 1Division of Gynecologic Oncology, Department of Obstetrics & Gynecology and Women's Health, Montefiore Medical Center, and Albert Einstein Cancer Center and the Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York.

Obstetrics and Gynecology
|August 5, 2015
PubMed
Summary

Women using statins showed improved survival from endometrial cancer, particularly nonendometrioid types. Concurrent use of statin and aspirin further reduced disease-specific mortality, suggesting a protective effect in cancer treatment.

Related Experiment Videos

Last Updated: Apr 6, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Endometrial cancer is a common gynecologic malignancy.
  • The role of common medications in cancer survival is an area of ongoing research.

Purpose of the Study:

  • To investigate the association between 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitor (statin) use and polypharmacy with disease-specific survival in endometrial cancer patients.

Main Methods:

  • A retrospective cohort study included 985 endometrial cancer cases diagnosed between 1999 and 2009.
  • Disease-specific survival was analyzed using Kaplan-Meier curves and Cox proportional hazards models.
  • Adjustments were made for age, clinical stage, and radiation therapy.

Main Results:

  • Statin use was associated with improved disease-specific survival (81% vs. 74%, P=.03), particularly in nonendometrioid endometrial tumors (68% vs. 43%, P=.02).
  • Adjusted analysis showed a significant association between statin use and reduced mortality (hazard ratio 0.63, 95% CI 0.40-0.99).
  • Concurrent use of statins and aspirin was linked to substantially lower disease-specific mortality (hazard ratio 0.25, 95% CI 0.09-0.70) compared to no medication use.

Conclusions:

  • Statin therapy is associated with enhanced survival in patients with endometrial cancer, especially nonendometrioid subtypes.
  • Combined use of statins and aspirin may further improve disease-specific survival in endometrial cancer patients.